<DOC>
	<DOCNO>NCT02092038</DOCNO>
	<brief_summary>Trial determine safety neoadjuvant treatment concurrent temozolomide radiation therapy , follow surgery temozolomide .</brief_summary>
	<brief_title>Preoperative Chemoradiation Glioblastoma</brief_title>
	<detailed_description>Prior definitive treatment enrollment , patient undergo stereotactic biopsy lesion confirm histology lesion determine methylated methylguanine methyltransferase ( MGMT ) status . Standard image-guided stereotactic technique use . Patients treat conformal radiation therapy . Temozolomide give day prior radiation therapy last day radiation therapy . 4-6 week radiation therapy patient undergo craniotomy maximal safe resection . Temozolomide continue begin 4 week surgery . Imaging : MRI within 2 week prior start protocol . MRI 4 week chemoradiation therapy prior surgery . MRI within 48 hour surgery . MRI every 2 cycle chemotherapy every 2 month progression , 2 year .</detailed_description>
	<mesh_term>Glioblastoma</mesh_term>
	<mesh_term>Temozolomide</mesh_term>
	<mesh_term>Dacarbazine</mesh_term>
	<criteria>MRI lesion brain high probability glioblastoma potentially resectable location brain ( primary study population ) WHO performance status 02 ( allow comparison historical control ) Adequate hematological parameter : ( safety neutropenia temozolomide ) Consent obtain patient , patient give consent medical power attorney one assign , nearest relative ( require obtain consent ) Able MRI scan ( secondary endpoint MRI scan characteristic ) Willing radiation treatment participate center ( homogeneity treatment parameter ) Ages 1880 Unresectable tumor Absolute neutrophil count ( ANC ) less 1,200/μL Hemoglobin less 9.0g/dL Platelet count less 100,000/μL</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>glioblastoma</keyword>
	<keyword>temozolomide</keyword>
	<keyword>radiation therapy</keyword>
	<keyword>radiotherapy</keyword>
	<keyword>surgery</keyword>
	<keyword>pre-operative</keyword>
	<keyword>neoadjuvant</keyword>
</DOC>